Heart And Vascular Diseases
What's New
Last Posted: Apr 28, 2024
- 1-L Transcription of SARS-CoV-2 Spike Protein S1 Subunit.
Nahalka Jozef, et al. International journal of molecular sciences 2024 0 0. (8) - Disparities and Outcomes in the First and Second Year of the Pandemic on Events of Acute Myocardial Infarction in Coronavirus Disease 2019 Patients.
Dhaliwal Jasninder Singh, et al. Medicina (Kaunas, Lithuania) 2024 0 0. (4) - HLA-B and C Expression Contributes to COVID-19 Disease Severity within a South African Cohort.
Naidoo Lisa, et al. Genes 2024 0 0. (4) - Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system.
Wei Qi, et al. The Lancet. Digital health 2024 0 0. (5) e309-e322 - Interferons and interferon-related pathways in heart disease.
Tran Duc Tin, et al. Frontiers in cardiovascular medicine 2024 0 0. 1357343 - Lung volume measurement using chest CT in COVID-19 patients: a cohort study in Japan.
Otake Shiro, et al. BMJ open respiratory research 2024 0 0. (1) - The impact of hypertension on clinical manifestations of Omicron variant BA.1 infection in adult patients.
Wang Jingyu, et al. Microbiology spectrum 2024 0 0. e0416823 - Enhanced identification of familial hypercholesterolemia using central laboratory algorithms.
Shirin Ibrahim et al. Atherosclerosis 2024 393117548 - Modification of coronary artery disease clinical risk factors by coronary artery disease polygenic risk score.
Buu Truong et al. Med 2024 - Identifying dementia from cognitive footprints in hospital records among Chinese older adults: a machine-learning study.
Jiayi Zhou et al. Lancet Reg Health West Pac 2024 46101060 - The role of colchicine in the management of COVID-19: a Meta-analysis.
Elshiwy Kholoud, et al. BMC pulmonary medicine 2024 0 0. (1) 190 - Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial.
Christina Johnson et al. Implement Sci 2024 19(1) 30 - Prevalence of elevated lipoprotein(a) in cardiac rehabilitation patients - results from a large-scale multicentre registry in Germany.
Christoph Altmann et al. Clin Res Cardiol 2024 - The Evolution of Genetic Testing from Focused Testing to Panel Testing and from Patient Focused to Population Testing: Are We There Yet?
Lauren Gima et al. Clin Colon Rectal Surg 2024 37(3) 133-139 - Assessing Biological Age: The Potential of ECG Evaluation Using Artificial Intelligence: JACC Family Series.
Francisco Lopez-Jimenez et al. JACC Clin Electrophysiol 2024 - Deep learning evaluation of echocardiograms to identify occult atrial fibrillation.
Neal Yuan et al. NPJ Digit Med 2024 7(1) 96 - Development of a Non-Invasive Machine-Learned Point-of-Care Rule-Out Test for Coronary Artery Disease.
Timothy Burton et al. Diagnostics (Basel) 2024 14(7) - Many Models, Little Adoption-What Accounts for Low Uptake of Machine Learning Models for Atrial Fibrillation Prediction and Detection?
Yuki Kawamura et al. J Clin Med 2024 13(5) - Non-Invasive Heart Failure Evaluation Using Machine Learning Algorithms.
Odeh Adeyi Victor et al. Sensors (Basel) 2024 24(7) - Scalable Approach to Consumer Wearable Postmarket Surveillance: Development and Validation Study.
Richard M Yoo et al. JMIR Med Inform 2024 12e51171
More
About HLBS-PopOmics
HLBS-PopOmics is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to Heart and Vascular Diseases(H), Lung Diseases(L), Blood Diseases(B), and Sleep Disorders(S)...more
Content Summary
Common HLBS Health Categories
Site Citation:
Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders. Genet Med. 2018 Sep 10. doi: 10.1038/s41436-018-0118-1
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: